Novel Inpatient Automated Self-Adjusting Subcutaneous Insulin Algorithm: 3-Year Experience. An Observational Study
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgaf376 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Robert J Rushakoff und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, University of California, San Francisco, CA 94115, USA. Hauptthemen laut MEDLINE: Algorithms, Insulin, Hyperglycemia, Hypoglycemic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS, NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Context
Achieving inpatient glycemic control in patients who are nil per os (NPO), on enteral tube feedings (TF), or total parental nutrition (TPN) remains extremely challenging.
Objective
To determine if, for inpatients with hyperglycemia who are NPO, on TF, or on TPN, an automated self-adjusting subcutaneous rapid-acting insulin algorithm (SQIA) we developed and programmed into the electronic medical record (EMR) leads to improvements in glucose control compared to conventional insulin treatment (CI).
Methods
Retrospective cohort study using EMR data from September 3, 2020, to September 2, 2023, of all adult inpatients, comparing point-of-care (POC) glucose measurements between patients on SQIA vs CI and either NPO, or on TF, or on TPN. The analysis looked at the proportion of q4 hour POC glucose levels in the following ranges: hypoglycemia (<70 mg/dL), in range (71-180 mg/dL), moderate hyperglycemia (181-250 mg/dL), and severe hyperglycemia (>250 mg/dL).
Results
There were 5031 intervals (associated with 4310 hospitalizations) in which the patient was NPO or on TF or TPN and on the SQIA (73.5%) or CI (26.5%). The proportion of glucose values in the hypoglycemic and severely hyperglycemic ranges were significantly lower in the SQIA group vs the CI group (hypoglycemia: 0.65% vs 1.10%; difference −0.45%; −0.62 to −0.28%; P < .001; hyperglycemia: 5.40% vs 6.65%; difference −1.25%; −2.03% to −0.46%; P = .002). With glucocorticoids, severe hyperglycemia rates were lower for patients on SQIA, particularly those receiving high-dose glucocorticoids (11.1% lower).
Conclusion
Patients had a lower proportion of both hypoglycemic and severely hyperglycemic measurements when their blood glucose levels were managed using the SQIA than when managed using conventional physician-driven insulin orders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, University of California, San Francisco, CA 94115, USA.
- Institute of Nursing Excellence, University of California, San Francisco, CA 94115, USA.
- Department of Medicine, University of California, San Francisco, CA 94143, USA.
- Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Clinical Systems, University of California, San Francisco, CA 94143, USA.
- Department of Health Informatics, University of California, San Francisco, CA 94143, USA.
ORCID-Profile: Robert J Rushakoff, Suneil Koliwad, Cynthia Fenton, Michael A Kohn
Förderung
- NCATS NIH HHS
- NIH HHS
- National Center for Advancing Translational Sciences
- National Institutes of Health
- UCSF-CTSI
Zitieren
APA
Rushakoff, R. J., Rov-Ikpah, E., Lee, G., Mehta, P. B., San Luis, C., Johnson, C., Koliwad, S., Fenton, C., & Kohn, M. A. (2026). Novel Inpatient Automated Self-Adjusting Subcutaneous Insulin Algorithm: 3-Year Experience. An Observational Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf376
Vancouver
Rushakoff RJ, Rov-Ikpah E, Lee G, Mehta PB, San Luis C, Johnson C, et al. Novel Inpatient Automated Self-Adjusting Subcutaneous Insulin Algorithm: 3-Year Experience. An Observational Study. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf376
BibTeX
@article{Rushakoff2026,
author = {Rushakoff, Robert J and Rov-Ikpah, Esther and Lee, Gwendolyn and Mehta, Paras B and San Luis, Craig and Johnson, Craig and Koliwad, Suneil and Fenton, Cynthia and Kohn, Michael A},
title = {Novel Inpatient Automated Self-Adjusting Subcutaneous Insulin Algorithm: 3-Year Experience. An Observational Study},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgaf376}
}
EUVIMED